Supplementary Table S3 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Authors: Enriqueta Felip, Peiwen Kuo, Pilar Garrido et al.
Publication:
Published: Unknown date
Source: Crossref
Back to Search View Original Cite This Article

Abstract

<jats:p>&lt;p&gt;Response rates by treatment arm and Trop-2 median H-score subgroup in the Trop-2 biomarker evaluable population.&lt;/p&gt;</jats:p>

Keywords

trop2 presponse rates treatment median

Related Articles

Multidimensional characteristics and ecological risks of MPs in receiving waters from WWTP effluent

Xiu Xu, Wei Wang et al. - Unknown

Read More
Figure 4 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Enriqueta Felip, Peiwen Kuo et al. - Unknown

Read More
Charting the small-molecule universe from mass spectra with neuro-symbolic AI

Utku U. Acikalin, Dieqiao Feng et al. - Unknown

Read More
Supplementary Figure S5 from Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non–Small Cell Lung Cancer: Insights From the EVOKE-01 Study

Enriqueta Felip, Peiwen Kuo et al. - Unknown

Read More
Two new species of Trichoderma from agricultural soils in China

Ke-Lin Li, Li-Juan Mao et al. - Unknown

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0